$CVRX Cashflow Statement | Understand Stock

$CVRX

$1.45 +$0.03 (2.11%) Close

Financial Statements

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation
Depreciation of property and equipment
Loss on disposal of equipment
Amortization of deferred financing costs and loan discount
Loss on debt extinguishment
Changes in fair value of convertible preferred stock warrants
Changes in operating assets and liabilities:
Accounts receivable
Inventory
Prepaid expenses and other current assets
Accounts payable
Accrued expenses

Net cash used in operating activities
Cash flows from investing activities:
Purchase of property and equipment
Net cash used in investing activities
Cash flows from financing activities:
Proceeds from the exercise of common stock options
Proceeds from issuance of Series G Preferred Stock, net of fees
Proceeds from Employee Stock Purchase Plan
Payments related to reverse stock split
Proceeds from the issuance of common stock
Proceeds from debt financing
Debt financing costs
Repayment on debt financing
Net cash provided by financing activities

Effect of currency exchange on cash and cash equivalents
Net change in cash and cash equivalents
Cash and cash equivalents at beginning of year
Cash and cash equivalents at end of period
Supplemental Information:
Cash paid for interest
Cash paid for income taxes
ROU assets exchanged for lease liabilities

Comments